Our Recommendations
- Временные рекомендации по использованию вакцины BNT162b2, COVID-19, Pfizer - BioNTech, в соответствии с перечнем препаратов для применения в чрезвычайных ситуациях (2021)
- Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (2022)
- Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence (2022)
- Recomendaciones provisionales para utilizar la vacuna contra la COVID-19 elaborada por Pfizer y BioNTech, BNT162b2, en el marco de la lista de uso en emergencias: orientaciones provisionales, 8 de ene (2021)
- Временные рекомендации по использованию вакцины BNT162b2, COVID-19, Pfizer - BioNTech, в соответствии с перечнем препаратов для применения в чрезвычайных ситуациях: временные рекомендации от 8 января (2021)
New Publications
- Good practice statement on the use of variant-containing COVID-19 vaccines (2022)
- Временные рекомендации по использованию вакцины BNT162b2, COVID-19, Pfizer - BioNTech, в соответствии с перечнем препаратов для применения в чрезвычайных ситуациях: временные рекомендации от 8 января (2021)
- WHO recommendation Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – COMIRNATY® (2021)
- Recomendaciones provisionales para utilizar la vacuna contra la COVID-19 elaborada por Pfizer y BioNTech, BNT162b2, en el marco de la lista de uso en emergencias: orientaciones provisionales, 8 de ene (2021)
- Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing (2022)
Filter
23
Featured
Recommendations
6
New Publications
10
Language
Document type
Guidelines
15
Studies & Reports
3
Fact sheets
3
Manuals
2
Countries / Regions
Germany
2
Argentina
2
Brazil
2
Russia
2
Kazakhstan
1
Mozambique
1
Global
1
Latin America and the Carribbean
1
Belarus
1
Authors & Publishers
Publication Years
Category
COVID-19
7
Guidelines
3
Policies
1
Women & Child Health
1
Toolboxes
Biontech/Pfizer Comirnaty
23
Logistics & Supply
5
Immunization Guidelines
4
Country specific documents
2
Moderna
2
Booster Doses
2
Pediatrics
1
For Parents & Children
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
10 December 2020
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
Information about vaccine administration
временные рекомендации от 8 января 2021 г.
Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
updated version: 04/10/2021
Information about vaccine administration
обновленная версия от 04/10/2021
Информация о введении вакцин
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
